Latest Breaking News On - Tongfei wu - Page 1 : comparemela.com

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Jin hongCorey davisYannick debingLawrence blattAlina jucovKusum guptaJinlin houVeronica eamesTongfei wuLifesci communicationsExchange commissionExchange commission onAligos therapeutics incAligos therapeuticsEuropean associationScientific presentations

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jinlin houKusum guptaVeronica eamesLawrence blattYannick debingCorey davisAlina jucovTongfei wuJin hongAligos therapeutics incLifesci communicationsExchange commission onExchange commissionEuropean associationScientific presentationsLate breaking poster

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023 - Aligos Therapeutics (NASDAQ:ALGS)

-Presentations include a late breaking poster from an ongoing Phase 1b study of ALG-000184 demonstrating multi-log reductions in HBsAg, DNA, and RNA levels in subjects dosed for up to 36 weeks- -Data collectively

Corey davisLawrence blattTongfei wuJinlin houVeronica eamesYannick debingKusum guptaAlina jucovJin hongExchange commission onLifesci communicationsAligos therapeutics incExchange commissionEuropean associationScientific presentationsLate breaking poster

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Jin hongKusum guptaLawrence blattTongfei wuVeronica eamesCorey davisYannick debingJinlin houAlina jucovExchange commission onExchange commissionAligos therapeutics incLifesci communicationsTherapeutics presents dataLiver disease programsEuropean association

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

-Presentations include a late breaking poster from an ongoing Phase 1b study of ALG-000184 demonstrating multi-log reductions in HBsAg, DNA, and RNA levels in subjects dosed for up to 36 weeks- -Data collectively highlight company’s progress advanc.

Tongfei wuLawrence blattAlina jucovKusum guptaJin hongVeronica eamesJinlin houYannick debingCorey davisAligos therapeutics incLifesci communicationsExchange commissionExchange commission onEuropean associationScientific presentationsLate breaking poster